Outcomes of left atrial appendage occlusion with a coated device: primary analysis of HEAL-LAA | JACC: Clinical Electrophysiology

In this episode of the JACC: Clinical Electrophysiology podcast, Executive Editor Emile Daoud discusses the primary analysis of the HEAL‑LAA study. The paper by Oluseun Alli, et al, evaluates real‑world outcomes with a next‑generation, fluoropolymer‑coated left atrial appendage occlusion device. In 500 patients across 32 U.S. centers, the study demonstrated excellent early device sealing, no significant peri‑device leaks, and favorable safety outcomes through 12 months, offering timely insights into contemporary LAAC practice and post‑implant antithrombotic management.